新型六氢山酮素拼接异噁唑双螺环氧化吲哚类化合物的合成

以色酮-氧化吲哚合成子1与氧化吲哚3-烯烃硝基异噁唑2,在催化剂DABCO催化下,在氯仿中发生双Michael加成环化反应,合成了7个未见文献报道的六氢山酮素拼接异噁唑双螺环氧化吲哚类化合物3a~3g,产率78%~92%,dr值10/1~15/1,其结构经¹H NMR, ¹³C NMR和HR-MS（ESI-TOF）表征。     

新型吡唑啉酮-六氢山酮素-氧化吲哚衍生物的合成

以色酮-吡唑啉酮合成子与3-烯键氧化吲哚为原料,DABCO为催化剂,氯仿为溶剂,于室温发生分子间Michael加成反应后再发生分子内环化反应,合成了14个未见文献报道的吡唑啉酮六氢山酮素骨架拼接氧化吲哚3a~3n,产率75%~89%, dr值7/1~11/1,其结构经¹H NMR, ¹³C NMR和HR-MS（ESI-TOF）表征。     

新型色满酮并环己烷螺环氧化吲哚类化合物的合成

以色酮 氧化吲哚合成子与硝基苯乙烯,在催化剂DBU作用下,在二氯甲烷中发生Michael/Michael加成环化反应,合成了9个未见文献报道的新型色满酮并环己烷螺环氧化吲哚类化合物3a~3i产率72%~87%, dr值4/1~2/1, 其结构经¹H NMR, ¹³C NMR和HR-MS（ESI-TOF）表征确定。     

新型螺环六氢山酮素-氧化吲哚-苯并呋喃酮类拼接物的合成及其抗白血病细胞增殖活性

以色酮-氧化吲哚合成子与3-烯基苯并呋喃酮为原料,在催化剂1,8-二氮杂二环十一碳-7-烯作用下,在二氯甲烷中发生Michael/Michael加成关环反应,合成了6个未见文献报道的螺环六氢山酮素-氧化吲哚-苯并呋喃酮类拼接物(3a^3f),产率75%~87%,dr值3/1~5/1,其结构经1H NMR,13C NMR和HR-MS(ESI-TOF)表征。采用MTT法研究了3a^3f对人白血病细胞(K562)的体外抗增殖活性。结果表明:化合物3c,3e和3f对K562增殖有一定的抑制活性。     

新型异噁唑山酮素骨架螺环氧化吲哚类化合物的合成

本文以色酮-氧化吲哚合成子(1)与硝基异噁唑苯乙烯(2),催化剂DBU作用下,经分子间Michael加成,分子内Michael加成环化反应,获得7个新型异噁唑山酮素骨架螺环氧化吲哚类化合物3a~3g,产率87%~93%,dr=8/1~15/1, 其结构经¹H NMR, ¹³C NMR和HR-MS（ESI-TOF）表征。      

无溶剂、无催化剂条件下合成1,4,5,6,7,8-六氢喹啉-5-酮衍生物

无溶剂、无催化剂条件, 在NH₄OAc存在下以查尔酮和1,3-二酮为原料, 高产率地合成1,4,5,6,7,8-六氢喹啉-5-酮衍生物. 该方法具有反应条件温和、操作简单和环境友好等优点. 并通过IR, ¹H NMR, 元素分析和X衍射确证产物的结构.     

多手性中心的螺-环丙烷类化合物的合成

研究了 5 (l 孟氧基 ) 3 溴 2 ( 5H) 呋喃酮新手性源 ( 1)与亲核性醇类化合物发生的串联不对称双Michael加成 /分子内亲核取代反应 ,通过此反应 ,一举生成了 4个新的手性中心 ,得到了一般方法难以合成的含有多个手性中心的丁内酯并螺 环丙烷类化合物 5a～ 5d .详细报道了 5a～ 5d的合成方法以及它们的 [α],IR ,UV ,1HNMR ,13 CNMR ,MS和元素分析等结构分析数据 .经X 四圆衍射确定了 5 (l 孟氧基 ) 3 溴代丁内酯并 [3,4,1″,2″] 螺 [4 .2 ] [环丙烷 3″,3′ ( 4′ 甲氧基 5′ 孟氧基丁内酯 ) ]( 5a)的立体化学结构 .此不对称串联反应为进一步设计某些光学活性的复杂结构的分子提供了重要的合成途径     

环戊-2-烯酮的研究Ⅰ.环戊-2-烯酮与醛反应的区域选择及非对映立体选择性

本文系统研究了环戊-2-烯酮在碱性条件下与醛类的羟醛缩合反应,并通过结构及过渡状态的分析,解释了所得的这类反应的区域及非对映立体选择性.     

新型二氢色原酮拼接多环吡咯螺环氧化吲哚类化合物的 无催化剂合成及其抗白血病活性

以取代的3-羧酸活化色酮、靛红与消旋脯氨酸为原料，乙腈为溶剂，依次经1,3-偶极子[3+2]环加成和脱羧反应，合成了8个新型的二氢色原酮拼接多环吡咯螺环氧化吲哚类化合物 (3a~3h)，产率68%~87%, dr值15/1~20/1,其结构经¹H NMR, ¹³C NMR和HR-MS（ESI-TOF）表征。采用MTT法研究了3a~3h对人白血病细胞(K562)的体外抑制活性。结果表明：化合物3d,3f, 3g对K562具有一定的抑制活性(IC₅₀=46.3~69.4 μmol·L^-1)。     

3-亚甲基六氢苯并呋喃-2(3H)-酮的简便合成

以氧化环己烯为原料,在正丁基锂作用下与乙腈经开环反应制得2-羟基环己基乙腈(2);2依次经水解、内酯化、二甲胺甲基化、甲基化和Hofmann降解反应合成了α-亚甲基-γ-丁内酯类化合物--3-亚甲基六氢苯并呋喃-2(3H)-酮,总收率30.4%,其结构经¹H NMR,¹³C NMR和HR-MS(EI)确证。     

A Diastereoselective Synthesis of Novel Multifunctional Thianes

The reaction of 2,2′-thiobis(1,3-diarylprop-2-en-1-ones) with malononitrile in the presence of sodium ethoxide under both thermal and solvent-free microwave conditions afforded a series of hitherto unknown 2e,6e-diaroyl-3e,5e-diaryl-4,4-dicyanothianes diastereoselectively in good yields via a double Michael addition. The structures of all the compounds have been elucidated by IR, ¹H NMR, ¹³C NMR, and elemental analysis.     

Stereoselective Synthesis of Novel Dispiro Oxindole-pyrrolothiazole-androsterone Hybrids

A facile synthesis of novel dispiro oxindole-pyrrolothiazole-androsterone hybrid heterocycles has been achieved through 1,3-dipolar cycloaddition. The reaction proceeds stereo- and regioselectively, affording a single isomer of the product in excellent yields with the formation of two C–C and one C–N bonds and creation of four new contiguous stereocenters in one step.     

新型吲唑-查尔酮杂合物的合成及抗肿瘤活性

设计并合成了一系列新型含查尔酮-吲唑杂合衍生物,并对其体外肿瘤活性进行初步研究。 先以2,6-二氟苯腈和吗啉为起始原料,经过取代和环合两步反应合成4-吗啉-3-氨基-1H-吲唑。 4-吗啉-3-氨基-1H-吲唑与含羧基的查尔酮中间体与经过酰胺化反应制备了9个新型含查尔酮-吲唑杂合衍生物,其结构经傅里叶变换红外光谱仪(FTIR)、核磁共振波谱仪(NMR)、质谱(MS)和元素分析确证。 采用MTT法,以索拉菲尼为阳性对照药,以人胃癌细胞株(MKN45)和人肺癌细胞株(A549)为测试细胞株对目标化合物进行抗肿瘤活性评价。 结果表明,大部分目标化合物显示了较好的抗肿瘤活性,其中化合物4a和4d活性较好,其抑制人胃癌细胞株MKN45的IC₅₀分别为2.65和3.55 μmol/L,均优于阳性对照药索拉菲尼(IC₅₀=4.69 μmol/L)。     

Synthesis and Antiproliferative Activity of Novel Dehydroabietic Acid-Chalcone Hybrids

Dehydroabietic Acid (DHA, 1) derivatives are known for their antiproliferative properties, among others. In the context of this work, DHA was initially modified to two key intermediates bearing a C18 methyl ester, a phenol moiety at C12, and an acetyl or formyl group at C13 position. These derivatives allowed us to synthesize a series of DHA-chalcone hybrids, suitable for structure–activity relationship studies (SARS), following their condensation with a variety of aryl-aldehydes and methyl ketones. The antiproliferative evaluation of the synthesized DHA-chalcone hybrids against three breast cancer cell lines (the estrogen-dependent MCF-7 and the estrogen-independent MDA-MB-231 and Hs578T) showed that eight derivatives (33, 35, 37, 38, 39, 41, 43, 44) exhibit low micromolar activity levels (IC₅₀ 2.21–11.5 μΜ/MCF-7). For instance, some of them showed better activity compared to the commercial anticancer drug 5-FU against MCF-7 cells (33, 41, 43, 44) and against MDA-MB231 (33 and 41). Hybrid 38 is a promising lead compound for the treatment of MCF-7 breast cancer, exhibiting comparable activity to 5-FU and being 12.9 times less toxic (SI = 22.7). Thus, our findings suggest that DHA-chalcone hybrids are drug candidates worth pursuing for further development in the search for novel breast cancer therapies.     

Diastereoselective Synthesis of Benzoxanthenones

An oxidative catalytic vanadium(V) system was developed to access the naturally nonabundant diastereomers of carpanone from the corresponding alkenyl phenol monomer in one pot by tandem oxidation, oxidative coupling, and 4+2 cyclization. This system was applied to the synthesis of two other analogues of carpanone. Mild oxidizing silver salts were used as the terminal oxidant to minimize background oxidation which produces the natural diastereomer of carpanone. Further, the first examples of enantioselective oxidative benzoxanthenone formation are reported. Solvent polarity has a strong effect on enantioselectivity, consistent with a mechanism involving binding of vanadium Schiff base catalysts to the alcoholic moiety of the alkenyl phenols during the cyclization step.     

Diastereoselective Synthesis of Nitroaldol Derivatives

Three methods are described by which diastereomerically enriched nitroaldols and their O-silylated derivatives can be prepared. threo-Nitroaldols prevail up to 10:1 over the erythro-isomers if doubly deprotonated nitroaldols 28 are quenched with acetic acid (THF/HMPT or DMPU, ? 100°) (see Scheme 5 and Table 2). O-Trimethyl- or O-(t-butyl)dimethylsilylated (TBDMSi) erythro-nitroaldols can be obtained by protonation of the corresponding lithium nitronates ( 35, 39 ) in THF at low temperature (see Schemes 6 and 7). The erythro-O-TBDMSi-nitroaldol derivatives are also formed in the fluoride catalyzed addition of TBDMSi-nitronates ( 40–45 ) to aldehydes (see Schemes 8 and 9), In the latter reaction no 1,2-asymmetric induction is observed if a-branched silylnitronates or aldehydes are employed (see 48/49 and 50/51 ) – The stereochemical course of the reactions leading to erythro-O-TBDMSi-nitroaldols follows topological rules of broad applicability (see Scheme 10); possible mechnisms are discussed. - The configuration of diasteromerically ¹³C-NMR. Spectroscopy. – Some examples of the preparation of diastereimerically enriched 1,2-aminolcohols by reduction of the correspondence nitro compounds without loss of configurational purity are described (see Schemes 11 and 12).     

Diastereoselective Synthesis of New Dialkylphosphorylhydrazones

A series of 22 dialkylphosphorylydrazones (dialkyl ester, N′-[(1E)-(R₁ phenyl)methylene]-phosphorohydrazidic acid), 20 of them new, along with three new N,N′-bis (diisobutylphosphorylthioamide)diamines (bis-[diisobutyl ester), N-thioxomethylene]-, diamine)phosphora-midic acid, were prepared and characterized by IR, ¹H NMR, ¹³C NMR, ³¹P NMR, and mass spectrometry. The analysis of ¹H NMR, ¹³C NMR, ³¹P NMR, and NOE spectra confirmed the observation of the single diastereoisomer E in the synthesis of dialkylphosphorylydrazones. The results of a molecular modeling study performed in order to investigate the mechanism of the synthesis of dialkylphosphorylydrazones are in agreement with the experimental results, i.e., the favored formation of diastereoisomer E over Z.     

Synthesis and Antitumor Evaluation of Novel Hybrids of Phenylsulfonylfuroxan and Estradiol Derivatives

Fifteen novel furoxan-based nitric oxide (NO) releasing hybrids of estradiol derivatives were synthesized and evaluated in vitro anti-proliferative activity in MDA-MB-231, A2780, Hela and HUVEC cell lines. Most of them displayed potent anti-proliferative effects. Among the compounds, 4-bromo-3-((phenylsulfonyl)-1,2,5-oxadiazole 2-oxide)-oxy-propoxy-estradiol ( 11 b ) exhibited the best activity with IC₅₀ values of 3.58–0.0008 μM. Preliminary pharmacological studies showed that 11 b induced apoptosis and hardly affected the cell cycle of MDA-MB-231 cell line. NO-releasing capacity and inhibition of ERK/MAPK pathway signaling might explain the potent antineoplastic activity of these compounds. The preliminary structure-activity relationship (SAR) showed that steroidal scaffolds with a linker in 3-position were favorable moieties to evidently increase the bioactivities of these hybrids. Overall, these results implied that 11 b merited to be further investigated as a promising anti-cancer candidate.